Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
THR vs BDC vs EMR vs ROK vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Communication Equipment
Industrial - Machinery
Industrial - Machinery
Conglomerates
THR vs BDC vs EMR vs ROK vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Communication Equipment | Industrial - Machinery | Industrial - Machinery | Conglomerates |
| Market Cap | $2.15B | $4.37B | $79.02B | $50.37B | $136.91B |
| Revenue (TTM) | $522M | $2.79B | $18.32B | $8.80B | $36.76B |
| Net Income (TTM) | $59M | $237M | $2.44B | $1.09B | $4.10B |
| Gross Margin | 44.8% | 35.8% | 52.7% | 52.5% | 36.9% |
| Operating Margin | 15.9% | 12.3% | 19.8% | 19.1% | 14.9% |
| Forward P/E | 30.8x | 14.2x | 21.7x | 36.9x | 20.5x |
| Total Debt | $152M | $1.47B | $13.76B | $3.65B | $34.58B |
| Cash & Equiv. | $40M | $390M | $1.54B | $468M | $12.49B |
THR vs BDC vs EMR vs ROK vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Thermon Group Holdi… (THR) | 100 | 407.5 | +307.5% |
| Belden Inc. (BDC) | 100 | 329.6 | +229.6% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| Rockwell Automation… (ROK) | 100 | 207.4 | +107.4% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THR vs BDC vs EMR vs ROK vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THR ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 251.9% 10Y total return vs ROK's 341.0%
- Lower volatility, beta 1.49, Low D/E 30.6%, current ratio 2.43x
- +136.2% vs HON's +2.8%
BDC has the current edge in this matchup, primarily because of its strength in growth exposure and valuation efficiency.
- Rev growth 10.3%, EPS growth 23.1%, 3Y rev CAGR 1.4%
- PEG 0.38 vs HON's 11.18
- 10.3% revenue growth vs THR's 0.7%
- Lower P/E (14.2x vs 20.5x), PEG 0.38 vs 11.18
EMR is the clearest fit if your priority is quality.
- 13.3% margin vs BDC's 8.5%
ROK is the clearest fit if your priority is efficiency.
- 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6%
HON is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Beta 0.74 vs EMR's 1.52
- 2.1% yield, 15-year raise streak, vs EMR's 1.5%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.3% revenue growth vs THR's 0.7% | |
| Value | Lower P/E (14.2x vs 20.5x), PEG 0.38 vs 11.18 | |
| Quality / Margins | 13.3% margin vs BDC's 8.5% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +136.2% vs HON's +2.8% | |
| Efficiency (ROA) | 9.7% ROA vs HON's 5.3%, ROIC 15.1% vs 12.6% |
THR vs BDC vs EMR vs ROK vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
THR vs BDC vs EMR vs ROK vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
BDC leads 1 • ROK leads 1 • THR leads 1 • HON leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 70.4x THR's $522M. Profitability is closely matched — net margins range from 13.3% (EMR) to 8.5% (BDC). On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $522M | $2.8B | $18.3B | $8.8B | $36.8B |
| EBITDAEarnings before interest/tax | $106M | $475M | $4.7B | $1.9B | $6.5B |
| Net IncomeAfter-tax profit | $59M | $237M | $2.4B | $1.1B | $4.1B |
| Free Cash FlowCash after capex | $55M | $180M | $3.1B | $1.3B | $4.2B |
| Gross MarginGross profit ÷ Revenue | +44.8% | +35.8% | +52.7% | +52.5% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +15.9% | +12.3% | +19.8% | +19.1% | +14.9% |
| Net MarginNet income ÷ Revenue | +11.3% | +8.5% | +13.3% | +12.4% | +11.2% |
| FCF MarginFCF ÷ Revenue | +10.5% | +6.5% | +17.0% | +15.2% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | +11.4% | +2.9% | +11.8% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +1.9% | +2.4% | +28.2% | +39.6% | -41.9% |
Valuation Metrics
BDC leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 19.0x trailing earnings, BDC trades at a 68% valuation discount to ROK's 58.5x P/E. Adjusting for growth (PEG ratio), BDC offers better value at 0.51x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.1B | $4.4B | $79.0B | $50.4B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $5.5B | $91.2B | $53.6B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 41.61x | 18.98x | 34.92x | 58.45x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.78x | 14.16x | 21.71x | 36.93x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | 1.21x | 0.51x | 7.73x | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 22.11x | 11.82x | 18.07x | 30.64x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 4.31x | 1.61x | 4.39x | 6.04x | 3.66x |
| Price / BookPrice ÷ Book value/share | 4.49x | 3.57x | 3.94x | 13.66x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 40.58x | 19.97x | 29.63x | 37.09x | 25.39x |
Profitability & Efficiency
ROK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $11 for THR. THR carries lower financial leverage with a 0.31x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs HON's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.9% | +18.8% | +12.1% | +29.6% | +23.1% |
| ROA (TTM)Return on assets | +7.2% | +6.8% | +5.8% | +9.7% | +5.3% |
| ROICReturn on invested capital | +9.8% | +11.0% | +8.2% | +15.1% | +12.6% |
| ROCEReturn on capital employed | +12.3% | +12.0% | +10.0% | +18.5% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.31x | 1.17x | 0.68x | 0.98x | 2.24x |
| Net DebtTotal debt minus cash | $112M | $1.1B | $12.2B | $3.2B | $22.1B |
| Cash & Equiv.Liquid assets | $40M | $390M | $1.5B | $468M | $12.5B |
| Total DebtShort + long-term debt | $152M | $1.5B | $13.8B | $3.6B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 10.25x | 6.89x | 6.46x | 9.06x | 3.92x |
Total Returns (Dividends Reinvested)
THR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in THR five years ago would be worth $32,890 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, THR leads with a +136.2% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors THR at 45.7% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +73.6% | -4.7% | +4.3% | +12.8% | +10.9% |
| 1-Year ReturnPast 12 months | +136.2% | +7.0% | +30.4% | +60.2% | +2.8% |
| 3-Year ReturnCumulative with dividends | +209.1% | +40.3% | +75.9% | +65.0% | +16.2% |
| 5-Year ReturnCumulative with dividends | +228.9% | +109.7% | +59.5% | +74.6% | +3.3% |
| 10-Year ReturnCumulative with dividends | +251.9% | +91.1% | +206.6% | +341.0% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +45.7% | +11.9% | +20.7% | +18.2% | +5.1% |
Risk & Volatility
Evenly matched — ROK and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 96.7% from its 52-week high vs BDC's 70.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 1.41x | 1.52x | 1.33x | 0.74x |
| 52-Week HighHighest price in past year | $71.24 | $159.99 | $165.15 | $463.49 | $248.18 |
| 52-Week LowLowest price in past year | $23.86 | $103.57 | $108.37 | $277.66 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +70.1% | +85.4% | +96.7% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 77.2 | 38.3 | 61.3 | 74.9 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 553K | 379K | 2.8M | 831K | 3.7M |
Analyst Outlook
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: THR as "Buy", BDC as "Buy", EMR as "Buy", ROK as "Hold", HON as "Buy". Consensus price targets imply 33.7% upside for BDC (target: $150) vs -12.7% for THR (target: $57). For income investors, HON offers the higher dividend yield at 2.14% vs BDC's 0.18%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $57.00 | $150.00 | $161.92 | $436.56 | $243.83 |
| # AnalystsCovering analysts | 15 | 14 | 41 | 39 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | +1.5% | +1.2% | +2.1% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 37 | 20 | 15 |
| Dividend / ShareAnnual DPS | — | $0.20 | $2.10 | $5.23 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +5.0% | +1.6% | +0.8% | +2.8% |
EMR leads in 1 of 6 categories (Income & Cash Flow). BDC leads in 1 (Valuation Metrics). 2 tied.
THR vs BDC vs EMR vs ROK vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is THR or BDC or EMR or ROK or HON a better buy right now?
For growth investors, Belden Inc.
(BDC) is the stronger pick with 10. 3% revenue growth year-over-year, versus 0. 7% for Thermon Group Holdings, Inc. (THR). Belden Inc. (BDC) offers the better valuation at 19. 0x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate Thermon Group Holdings, Inc. (THR) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THR or BDC or EMR or ROK or HON?
On trailing P/E, Belden Inc.
(BDC) is the cheapest at 19. 0x versus Rockwell Automation, Inc. at 58. 5x. On forward P/E, Belden Inc. is actually cheaper at 14. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Belden Inc. wins at 0. 38x versus Honeywell International Inc. 's 11. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — THR or BDC or EMR or ROK or HON?
Over the past 5 years, Thermon Group Holdings, Inc.
(THR) delivered a total return of +228. 9%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: ROK returned +341. 0% versus BDC's +91. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THR or BDC or EMR or ROK or HON?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Thermon Group Holdings, Inc. (THR) carries a lower debt/equity ratio of 31% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — THR or BDC or EMR or ROK or HON?
By revenue growth (latest reported year), Belden Inc.
(BDC) is pulling ahead at 10. 3% versus 0. 7% for Thermon Group Holdings, Inc. (THR). On earnings-per-share growth, the picture is similar: Belden Inc. grew EPS 23. 1% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, THR leads at 11. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THR or BDC or EMR or ROK or HON?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus 8. 7% for Belden Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 12. 2% for BDC. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THR or BDC or EMR or ROK or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Belden Inc. (BDC) is the more undervalued stock at a PEG of 0. 38x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Belden Inc. (BDC) trades at 14. 2x forward P/E versus 36. 9x for Rockwell Automation, Inc. — 22. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BDC: 33. 7% to $150. 00.
08Which pays a better dividend — THR or BDC or EMR or ROK or HON?
In this comparison, HON (2.
1% yield), EMR (1. 5% yield), ROK (1. 2% yield), BDC (0. 2% yield) pay a dividend. THR does not pay a meaningful dividend and should not be held primarily for income.
09Is THR or BDC or EMR or ROK or HON better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). Both have compounded well over 10 years (HON: +135. 1%, BDC: +91. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THR and BDC and EMR and ROK and HON?
These companies operate in different sectors (THR (Industrials) and BDC (Technology) and EMR (Industrials) and ROK (Industrials) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
EMR, ROK, HON pay a dividend while THR, BDC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.